K-numberK251483
Device nameSwiftSight-Brain
ApplicantAirs Medical, Inc.
Product codeQIH
Device classClass II
Decision dateSep 23, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

SwiftSight-Brain is an automated MRI image analysis software that automatically segments, labels, and measures volumes of brain structures and lesions from 3D T1-weighted and T2-weighted FLAIR MRI scans. It generates morphometric reports comparing measured volumes to age and gender-matched reference percentile data and is intended to support clinicians in assessment of structural MRIs.

Technological characteristics

SwiftSight-Brain uses deep learning for automated segmentation and quantification of brain structures, operates as software on Windows-based off-the-shelf hardware, processes DICOM-format MRI input through an automated pipeline, and outputs segmented color overlays with morphometric reports for PACS display. It includes automated quality control functions such as tissue contrast checks and scan protocol verification, matching the predicate device's core functionality.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

The device is substantially equivalent because it shares identical intended use, target anatomical site (brain), processing architecture, data source (3D T1 and FLAIR MRI), and output format (segmented images and morphometric reports) with the predicate Neurophet AQUA V3.1. Performance validation demonstrates equivalent accuracy (Dice coefficients >80% for subcortical structures, >75% for cortical) and reproducibility (≤5% volume differences) compared to expert manual segmentation. Minor terminology differences in quality control functions and user qualifications do not introduce new safety risks and do not affect the device's safety or effectiveness.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →